Urinary G3BP test for lupus kidney disease
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This trial studies whether a protein called G3BP in urine can help diagnose lupus kidney disease. It compares patients with lupus nephritis, lupus without kidney problems, and other types of kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older
- Either have lupus nephritis (diagnosed by kidney biopsy), lupus without kidney disease, or another type of kidney disease (like post-infectious glomerulonephritis)
- Not be pregnant
- Must agree to participate in the study
- Kidney function must not be severely reduced (estimated GFR of 15 ml/min or more)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called IPG11406 for people with active lupus nephritis, a type of kidney inflammation caused by lupus. It aims to see if the drug can help reduce kidney damage and improve symptoms.
This trial tests a new treatment called PRG-1801 for people with lupus nephritis (kidney inflammation from lupus) or IgG4-related disease that has not improved with standard treatments. The treatment uses your own immune cells to target and calm the disease.
This study looks at whether a specific antibody (anti-alpha-actinin) in the blood is linked to active lupus kidney disease. It may help doctors better understand and monitor kidney problems in people with lupus.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
This study looks at two simple blood tests to see if they can help doctors understand and predict how lupus-related kidney disease (lupus nephritis) is progressing. The goal is to improve monitoring and treatment decisions for people with this condition.
Hear when a new Lupus Nephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.